Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-05-14 @ 9:05 PM
Study NCT ID:
NCT04556669
Status:
UNKNOWN
Last Update Posted:
2021-05-27
First Post:
2020-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Conditions & Keywords Data
Conditions: